Kadimastem Ltd (TLV:KDST)
2,565.00
-27.00 (-1.04%)
Aug 5, 2025, 4:43 PM IDT
AY Market Cap
Kadimastem has a market cap or net worth of 107.36 million as of August 5, 2025. Its market cap has increased by 311.18% in one year.
Market Cap
107.36M
Enterprise Value
114.71M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2,565.00
Market Cap Chart
Since June 13, 2013, Kadimastem's market cap has increased from 72.88M to 107.36M, an increase of 47.31%. That is a compound annual growth rate of 3.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 4, 2025 | 108.70M | 102.18% |
Dec 31, 2024 | 53.76M | 116.19% |
Dec 31, 2023 | 24.87M | -37.96% |
Dec 29, 2022 | 40.08M | -66.07% |
Dec 30, 2021 | 118.12M | 197.88% |
Dec 31, 2020 | 39.65M | -27.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 61.46B |
Danel (Adir Yeoshua) | 2.66B |
Kamada | 1.41B |
Bait Bakfar | 1.11B |
SofWave Medical | 867.69M |
BrainsWay | 750.26M |
Novolog (Pharm-Up 1966) | 701.94M |
Ilex Medical | 674.08M |